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Background: There is increasing recognition among trialists of the challenges in understanding how particular
‘real-life’ contexts influence the delivery and receipt of complex health interventions. Evaluations of interventions to
change health worker and/or patient behaviours in health service settings exemplify these challenges. When
interpreting evaluation data, deviation from intended intervention implementation is accounted for through
process evaluations of fidelity, reach, and intensity. However, no such systematic approach has been proposed to
account for the way evaluation activities may deviate in practice from assumptions made when data are
interpreted.
Methods: A collective case study was conducted to explore experiences of undertaking evaluation activities in the
real-life contexts of nine complex intervention trials seeking to improve appropriate diagnosis and treatment of
malaria in varied health service settings. Multiple sources of data were used, including in-depth interviews with
investigators, participant-observation of studies, and rounds of discussion and reflection.
Results and discussion: From our experiences of the realities of conducting these evaluations, we identified six
key ‘lessons learned’ about ways to become aware of and manage aspects of the fabric of trials involving the
interface of researchers, fieldworkers, participants and data collection tools that may affect the intended production
of data and interpretation of findings. These lessons included: foster a shared understanding across the study team
of how individual practices contribute to the study goals; promote and facilitate within-team communications for
ongoing reflection on the progress of the evaluation; establish processes for ongoing collaboration and dialogue
between sub-study teams; the importance of a field research coordinator bridging everyday project management
with scientific oversight; collect and review reflective field notes on the progress of the evaluation to aid
interpretation of outcomes; and these approaches should help the identification of and reflection on possible
overlaps between the evaluation and intervention.
Conclusion: The lessons we have drawn point to the principle of reflexivity that, we argue, needs to become part
of standard practice in the conduct of evaluations of complex interventions to promote more meaningful
interpretations of the effects of an intervention and to better inform future implementation and decision-making.
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Increasing attention has been paid to understanding ‘what
works’, for whom and under what circumstances in order
for evaluations of health and health service interventions to
be useful in informing wider implementation [1,2]. There is
a growing body of literature on evaluations of complex in-
terventions defined as interventions with multiple, interact-
ing components [3-6], such as behavioural interventions in
health service settings which may have several dimensions
of complexity and include subjectively-measure outcomes
e.g., [7]. Within this literature there has been particular
focus on the most appropriate research designs through
which to evaluate these types of complex interventions
[8,9], with guidance on selecting and measuring outcomes
[5,6] and on evaluating the implementation processes and
the influence of context on the delivery of an intervention,
and on its effect [10,11]. Through our experiences of
evaluating complex behavioural interventions in ‘real-life’,
low-income, health service settings, we have become aware
of the importance for validity of data of the dynamics at the
interface of researchers, fieldworkers, participants, and data
collection tools that form the fabric of the evaluation com-
ponents of trials. We have been unable to identify guidance
or any systematic approach to being alert to and managing
issues arising at these interfaces during the enactment of
evaluation activities that may influence how emerging data
can be interpreted.
For research conducted in ‘real-life’ settings, it cannot
be assumed that the delivery of a complex intervention
or its evaluation will be exactly as planned or intended in
the design stage of a trial. Literature on process evaluation
highlights the importance of taking a systematic approach
to documenting and accounting for this deviation, report-
ing the actual implementation, receipt and setting of
an intervention in order to interpret its effects [12,13].
Within this literature, it is acknowledged that understand-
ing the dynamics between the trial context and the nature
of the intervention is important for interpreting the mech-
anisms of effect of an intervention and its potential trans-
ferability [14]. However, as the formal objective of process
evaluation is to investigate the delivery of the intervention
[15], this research practice does not typically extend to
considering (or reporting on) the dynamics between the
trial context and evaluation activities, and their potential
implications for interpreting trial data. A number of studies
have explored and reported on particular aspects of the de-
livery of the evaluation of an intervention, for example the
recruitment and consent procedures of a trial [16], or major
adverse events arising which led to the discontinuation
of a trial arm [17]. While such examples offer a snapshot of
processes and interactions that may occur during an evalu-
ation, they fall short of proposing a systematic approach
to becoming aware of and managing the dynamics of data
generation through the whole process of conductingevaluation activities in real-life contexts, as has been
adopted in process evaluations of intervention delivery [14].
We consider data generation in a trial to be a set of pro-
cesses and influences that are embedded in a network of
objects, people, concepts, goals and relationships. This net-
work constitutes both the trial activities—the delivery of the
intervention and evaluation—and also the context in which
they are conducted [18]. Figure 1 draws on the key stages
of the development, evaluation, and implementation of a
complex intervention depicted in recent guidance from the
Medical Research Council [4], and we highlight the evalu-
ation stage, situated within this influencing network, or the
‘fabric’ of the trial in real life. Thus, we draw attention to
the purpose of this paper: to consider the reality of ‘doing’
evaluation of an intervention and how it may contribute to
interpretations of trial outcomes.
In this paper, we reflect on our own experiences of the
need to respond to challenges arising during the execu-
tion of evaluation activities as part of a trial or similar
research study of an intervention. Existing literature re-
lating to evaluation practices focuses on project or trial
management, research ethics and quality assurance.
Trial management literature aims to ensure the efficient
operationalization of a trial within budget and time con-
straints; e.g., the Clinical Trials Toolkit [19]. Research
ethics literature incorporates the standard codes upheld
by ethics and institutional review boards as well as explor-
ing how ethical practices and issues are negotiated in local
trial contexts e.g., [20,21]. Literature on quality assurance
in trials has focused on internal validity through the stand-
ardisation of research processes [22,23], and promotes the
use of independent boards to monitor progress of the trial
and safety data against critical interim and endpoints [24].
However, a gap remains regarding the dynamics of
conducting the evaluation component of trials in practice
[25]. There is no cohesive guidance for researchers on
how to consider the potential implications of real-time
decisions made when enacting evaluation activities for the
interpretation of trial results. In this paper, we will draw
on our experiences of ‘doing’ evaluation in a research con-
text to present lessons learned for negotiating the reality
of evaluation and reflecting on the subsequent implica-
tions for interpreting trial outcomes.
Methods
Our research context
We draw on our experiences of conducting research-
focused evaluations of interventions to improve malaria
diagnosis and treatment in real-life health service settings,
as part of the ACT Consortium (www.actconsortium.org).
Nine ACT Consortium studies, in six countries in Africa
and Asia, have used a range of methods to evaluate in-
terventions that target health worker and/or patient
behaviours in relation to the appropriate diagnosis and
Development
1 Idenfying the evidence base
2 Idenfying/developing theory
3 Modelling process and outcomes
Feasibility/Pilong
1 Tesng procedures
2 Esmang recruitment/retenon
3 Determining sample size
Implementaon
1 Disseminaon
2 Surveillance and monitoring
3 Long term follow-up
Network of people, objects, concepts and relaonships 
within which the ‘doing’ of evaluaon acvies is engaged
Evaluaon
1 Assessing eﬀecveness
2 Understanding change process
3 Assessing cost-eﬀecveness
Figure 1 Focus on ‘doing’ evaluation. Adapted from Medical Research Council [4], this diagram shows the stages of the process of a complex
intervention, highlighting the stage of ‘doing’ evaluation activities in a real-life setting, which is the focus of this paper.
Reynolds et al. Implementation Science 2014, 9:75 Page 3 of 12
http://www.implementationscience.com/content/9/1/75treatment of malaria. They are located in settings
where overdiagnosis of malaria and unnecessary prescrip-
tion of antimalarials are commonplace. This is typically
underpinned by an entrenched practice of presumptive
treatment of malaria by health workers, even when diag-
nostic facilities are available, and by a range of social influ-
ences including patient expectations when seeking care
for febrile illness e.g. [26-28]. The interventions can be
defined as complex [6]; they comprise multiple different
and interacting components, require considerable shifts in
behaviours by intervention recipients, involve a variety of
outcome measures, and are implemented at various levels
of low-resource health services, including public health fa-
cilities, community health workers and private drug ven-
dors. See Table 1 for a summary of the studies represented
in this paper.
Studies were designed to enable rigorous evaluation of
the effects of interventions with the intention to inform
policy and programmes in the future implementation of
malaria diagnostics and treatment [27]. The design of
the studies, therefore, had to balance needs for internal
validity—an accurate representation of whether an inter-
vention ‘works’ in a given setting—and external validity—
the ability to generalise the results beyond a specific
scenario, through careful evaluation designs [29]. Despite
careful planning and piloting, we encountered a number
of challenges and made a number of changes in the imple-
mentation of evaluation activities that we had to take into
account in interpreting the data produced.
Methodological approach
To elicit experiences and generate ‘lessons learned’,
we used a collective case study design [30] based onan iterative, reflexive approach to study multiple cases
of studies within their real-life contexts [31]. Each study
in Table 1 was considered a case, unique in their combi-
nations of research question, setting, and research team.
Links existed between all cases through some investigators
contributing to multiple studies and all being connected
under the collaborative umbrella of the ACT Consortium.
We sought to explore experiences of the implementa-
tion of our evaluation activities within three key do-
mains: challenges and opportunities faced in the field
when implementing evaluation activities; how these
challenges/opportunities were negotiated (or not); and
perceived impact of these challenges/opportunities and
consequent actions taken.
We drew on multiple sources of information including
in-depth interviews with investigators and study coordi-
nators; rounds of discussion and reflection among those
connected to the studies and those providing overarching
scientific support across the ACT Consortium; informal
participant-observation by JR, DD, and CIRC via engage-
ment with studies as they were conducted; and reflection
on study activities, documentation, and interpretation.
The internal, embedded perspective of this set of methods
enabled us to draw on our ‘institutional knowledge’ of the
cases and their contexts in a way that would be extremely
difficult for someone external to the studies. Our reflec-
tions were also supported by reviews of relevant literature
to situate and interpret our experiences within a wider
context of experimental research in low-income country
settings. Formal analysis was conducted of the transcribed
in-depth interviews using a framework approach [32], and
this was used to provide an initial summary of experiences
that formed the basis of further reflection, discussion and
Table 1 Summary of studies represented in this paper
ACT Consortium
study1 and location
Study aims Evaluation activities conducted
1, Uganda Cluster randomised trial (CRT) to evaluate an intervention
package to enhance health facility care for malaria and
febrile illnesses in children.
1) Cross-sectional community surveys; 2) cohort study of
children; 3) patient exit interviews; 4) health centre surveillance;
5) key informant in-depth interviews (IDIs) and questionnaires;
6) community focus group discussions (FGDs).
2, Uganda CRT to evaluate the cost-effectiveness of artemisinin-based
combination therapies (ACTs) following the introduction
of rapid diagnostic tests (RDTs) for the home-management
of malaria at the community level.
1) Blood slide readings to assess appropriateness of treatment;
2) follow-up household and morbidity surveys 3) FGDs and IDIs
with community medicine distributors and community members.
3, Uganda CRT to evaluate the impact of introduction of RDTs to
drug shops on the improvement of rational drug use for
case management of malaria.
1) Blood slide readings to assess appropriateness of treatment;
2) follow-up household surveys; 3) FGDs with drug vendors,
carers and health workers; 4) adverse event surveillance.
4, Tanzania Before-and-after observational evaluation of interventions
to increase access to RDTs in public facilities and to ACTs
in public and private facilities.
1) Household, health facility and outlet surveys; 2) post-intervention
key informant interviews; 3) mixed qualitative methods including
mapping exercises; rapid assessments of communities, IDIs
and FGDs.
5 (a), Cameroon CRT to evaluate basic and enhanced provider interventions
to improve malaria diagnosis and appropriate use of ACTs
in public and mission health facilities.
1) Intervention delivery evaluation (questionnaires, stocking
records); 2) patient exit survey; 3) analysis of facility records and
facility audit; 4) provider survey.
5 (b), Nigeria CRT to evaluate provider & community interventions to
improve malaria diagnosis using RDTs and appropriate use
of ACTs in public health facilities and private sector
medicine retailers.
1) Intervention delivery evaluation (questionnaires, stocking
records, records of school-based intervention); 2) patient exit
survey; 3) analysis of facility records and facility audit; 4) provider
survey; 5) household survey.
6, Afghanistan Individually randomised trial (IRT) and CRT evaluating an
intervention to improve diagnosis and appropriate
treatment of malaria with RDTs at health clinic level, and
among community health workers.
1) Clinic based data collection; 2) entry and exit interviews with
patients; 3) IDIs with health workers; 4) data collected from
community health workers.
9, Tanzania CRT evaluating health worker and patient oriented
interventions to improve uptake of RDTs and adherence
to results in primary health facilities.
1) Health facility data collection; 2) patient exit interviews;
3) intervention delivery evaluation (observations, questionnaires, IDIs);
4) follow-up household survey; 5) IDIs with health workers.
15, Ghana IRT to evaluate an intervention to introduce RDTs to health
facilities to improve diagnosis and appropriate treatment
of malaria.
1) IDIs with health workers; 2) FGDs with community members.
Conducted via a separately funded project: 3) blood slide reading
to assess appropriateness of treatment; 4) health facility-based
data collection; 5) follow-up household survey.
1See the ACT Consortium website, www.actconsortium.org, for more information on each of these studies.
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and July 2013.
This research was conducted as an internal exercise
within the ACT Consortium, involving only the authors
and their reflection on their own experiences; as such,
ethical approval was not sought beyond the original eth-
ical approvals granted for each of the individual studies
represented here.
Results and discussion
Lessons learned from implementing evaluation activities
We interpreted a set of first order constructs from across
our collective experiences, and have categorised these as a
set of ‘lessons learned’ from the implementation of evalu-
ation activities and from our reflections on the potential
implications of decisions made during the evaluation in
response to contextual changes and influences. These in-
fluences included the networks of relationships, cultures,
and expectations within which evaluation activities were
conducted. Each lesson is described below with an over-
view, drawn from collective reflection and interpretationacross the different cases, and with one or more specific
examples from the cases and further interpretation through
reference to existing literature. Although not every case
contributed examples for every lesson, each lesson repre-
sents the interpretation of experiences from across multiple
cases. A summary of the six lessons is presented in Table 2,
and examples of experiences from across the different stud-
ies, which contributed to the identification of each lesson,
are presented in Additional file 1.
Training the study team to generate a shared
understanding of objectives
Training of study staff, including field workers (the ‘field
team’) and study coordinators, is a fundamental, and per-
haps obvious, component of the planning and preparation
for conducting evaluation activities as part of an interven-
tion trial. Ensuring staff responsible for data collection, data
management, and other activities at the ‘front-line’ of an
evaluation are familiar with the study protocol and stand-
ard operating procedures (SOPs) is undeniably important.
However, we should not assume that such training will
Table 2 Summary of the lessons learned from our experiences of ‘doing’ evaluation
Lesson learned Summary of learning
1. Different interpretations of study objectives
and ‘success’ among team
Through pre-intervention and ongoing training, foster a shared understanding across the
entire study team of why data are being collected, the processes and goals valued in the
study and how individual practice feeds into the study’s rationale and outcomes.
2. Value of good communications to address
challenges as they arise in the field
Plan intra-study communications structures carefully to ensure staff at all levels feel
empowered to engage in reflection on the progress of the evaluation and interpretation
of its outcomes, for example through frequent, supportive meetings and clear mechanisms
for reporting and managing issues that arise.
3. Dialogue between different components of
the evaluation
Establish mechanisms for ongoing collaboration between sub-study teams, to share
experiences and observations from across study components, to encourage interpretation
of research activities as the trial progresses, and to facilitate the synthesis of data from
different disciplinary perspectives at the analysis stage.
4. Value of role of field research coordinator Recognise, and support, the vital role of a field research coordinator in bridging the
everyday, practical project management of a study, with an ongoing, scientific interpretation
of evaluation activities, which can feed into generating meaningful results.
5. Value of collecting field notes during evaluation Promote a continuous, inward reflection on the activities of an evaluation among team
members through mechanisms for collecting, regularly reviewing and storing field notes,
helping to make more meaningful interpretations of trial results at the analysis stage.
6. Recognition of, and reflection on, overlap
between intervention and evaluation
In addition to careful planning and piloting of evaluation activities, the establishment,
and maintenance, of the processes and structures described above should help the timely
identification of and reflection on possible overlaps between intervention and evaluation
activities, to feed into interpreting the trial results and usefully informing future
implementation of the intervention.
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study objectives and research values as held by those
with more scientific responsibility for the project. Particu-
larly in evaluations of behavioural interventions, where
outcomes are reported by participants or observed by field
teams rather than objectively measured, a field worker’s
understanding of the trial objectives will influence the way
in which this data is elicited and recorded.
Although training of study teams was conducted prior
to the commencement of evaluation activities in each of
our projects, several scenarios arose which seemed to re-
flect differing interpretations of study objectives among
study staff, particularly in what constituted ‘success’ of the
project. Field teams sometimes appeared to equate success
with active uptake and use of intervention technologies and
ideas, suggesting that the intervention was ‘working’ as
hoped or expected. By contrast, investigators saw success
as the ability to evaluate whether (and why) an intervention
was working and was taken up. In the cluster randomised
trial in Afghanistan, trial staff reported giving corrective
assistance to community health workers (CHWs) receiving
the intervention, some of whom had conveyed during the
data collection for evaluation that they had struggled to
interpret correctly the result of the rapid diagnostic test
(RDT) for malaria. Although a rare occurrence, when these
difficulties were identified in the field trial staff felt it was
important to provide additional advice to CHWs to im-
prove their use of the RDT in line with the intended
intervention and their diagnosis practices of malaria,
thus potentially influencing the evaluation of the interven-
tion’s success. The investigators recognised that this po-
tentially compromised their research aim to evaluate therollout of RDTs in the community in a ‘real-world’ setting
in Afghanistan, where such supervision and feedback on
CHWs’ practice were not commonplace. A decision was
made not to restrict trial staff from advising CHWs, but to
record and consider the likely effect of this at the analysis
stage. In this example, the research aims of the trial were
undermined by field staff ’s concern for improving malaria
diagnosis. Their activities, seen as ‘evaluation’ by the trial,
in practice incorporated an additional ‘intervention’ activity.
Good communication within the team, achieved through
regular calls and close working relationships between the
lead investigators and field staff, meant these additional
activities could be known, recorded, and a decision made
by the investigators to document such occasions.
It is important to remember that staff members re-
sponsible for enacting evaluation activities may hold dif-
ferent perspectives of a study’s objectives, which can
influence the implementation of evaluation activities,
despite the presence of, and training on, study protocols
and SOPs [25]. In the Afghanistan example, these differ-
ing perspectives included the lead investigators’ con-
cerns towards evaluating the intervention in the ‘real’
context into which it would likely be scaled-up and the
field team’s concerns towards improving diagnosis and
treatment of malaria in the local communities in which
they were situated. The enactment of evaluation activ-
ities may thus reflect negotiations between different sets
of objectives held among staff including the scientific
trial objectives, personal objectives of being seen to do a
‘good job’ within the context of the study, and objectives
towards the welfare of the groups of people directly en-
gaged in the study.
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surrounding community have been explored in recent
literature on research ethics ‘in practice’ e.g., [21]. The
process of producing high-quality data is a subjective,
creative one, underpinned by particular values of what
constitutes ‘dirty’ or ‘clean’ data [33,34]. As such, it is
crucial to ensure that there is a shared understanding
across the whole study team of the specific values held
by those leading the research from a scientific perspec-
tive. Both content and timing of training can facilitate
this. The content of training should extend beyond the
practicalities of simply how to collect or manage data in
line with SOPs, to an emphasis on why data are being
collected, what processes and goals are valued within the
project, and how staff members’ practices feed into
these. Pre-trial training is required, but ongoing training,
whether formal or more informal through regular super-
vision and feedback, will generate a greater understand-
ing of a study’s rationale and objectives. Integrating this
training within the day-to-day activities of staff will offer
opportunities to address challenges they face, for ex-
ample, negotiating personal and trial priorities. It should
also help to ensure a heightened awareness among staff
of their practices, and provide opportunities for reflec-
tion and dialogue within the study teams of how these
challenges, negotiations, and practices influence the out-
comes of a study.
Promoting communications within the study team
The need for good communication between members of
a study team is well recognised, and its role in the effect-
ive management of a research project is of little debate.
It is important to consider in more detail the communi-
cation structures within a study and what information
should be shared during the roll out of an evaluation.
These elements may influence what study team members
consider necessary to share about ongoing evaluation
activities, their motivation to do so, and the subsequent ac-
tions taken. We recognised the value of having structures
in place enabling the timely sharing of information about
issues that arose while staff members were implementing
evaluation activities, including contextual changes in
the field, interactions between evaluation and interven-
tion activities, and other unexpected events or compli-
cations. This helped bring awareness to the day-to-day
progress of the evaluation and facilitated responsiveness
of more senior staff to scenarios that had implications for
meaningful interpretation of the data.
Investigators from several studies reflected on the
value of a close communication system during evalu-
ation, for example in Ghana (study 15), where regular
meetings were held involving the field staff, study coor-
dinators, senior investigators, and principal investiga-
tor. These meetings were considered to have enabledfield staff to raise challenges they faced during evaluation,
such as how to manage clinicians’ questions about the
high number of negative malaria test results produced
without greatly influencing the nature of the interven-
tion received by participants. As a result, a decision was
made for field workers to advise clinicians to continue
to ‘do what they would normally do’, until after the
period of data collection when feedback on the use and
interpretation of diagnostic tests was given to the par-
ticipating clinicians. In one study in Tanzania (study 4),
investigators highlighted the importance of a responsive
communication system during evaluation. One investi-
gator described challenges faced in the field with meet-
ing the sampling targets for the evaluation activities in
some areas, due to reported contextual changes such as
shifts in malaria control strategies and the epidemiology
of fever in these areas. The investigator found it extremely
valuable to have a system through which the problems
field workers faced with recruitment, and the underlying
contextual factors, could be communicated to her rapidly.
This enabled her to seek advice from the study statistician
and for ‘on-the-hoof sample size discussions’ to be held to
inform quickly how recruitment activities in the field
should progress, without delaying them. Another investiga-
tor from this study also highlighted the value of having a
team leader who was able to communicate well with the
field staff to detect any problems they were facing in their
work, and was also empowered to communicate further up
the chain to the study coordinators, to enable timely deci-
sions to be made, and their scientific impact considered.
Members of field teams have been described previously
as holding a difficult position with conflicting responsibil-
ities and accountability both toward the research project
and toward its ‘participants’, with whom they may have
existing direct or indirect social relationships, obligations or
expectations [35]. For example, field staff may feel obliged
to extend services to the neighbours of a household ran-
domly allocated to ‘receive’ evaluation activities such as
testing (and subsequent treatment) for malaria. Barriers
to field staff reporting challenges they face in negotiating
field activities, including interactions with participants and
the framing, phrasing, or ordering of questions or proce-
dures, may reflect these social positions, as well as a lack
of understanding of the potential (scientific) implications
of such challenges for the study. This may be made more
difficult by trial management structures; in all of our trial
settings a strong hierarchical structure was apparent,
reflecting the ‘command and control’ structure of health
organizations in many African countries [36]. We found it
necessary to try to counteract these hierarchies by encour-
aging dialogue ‘up’ to those with scientific responsibility
for studies, together with demonstration that issues raised
were taken seriously. Engagement of all staff in reflection
on the approach to, and progress of, the evaluation and
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provide a greater sense of satisfaction, particularly among
lower level staff members, in their role in the research
process [37]. Moreover, this may promote and legitimize a
heightened perception of responsibility towards the study’s
objectives, increase team reflexivity on their practices and
how they contribute to the production of results, and con-
tribute to increased rigour and quality of research activities
[38]. We recommend careful planning of communication
structures to include frequent meetings where engagement
of staff at all levels is encouraged in a supportive, reflective
environment, and clear mechanisms for reporting chal-
lenges faced, decision making, and giving prompt responses
in decision making.
Ongoing dialogue between different components of
the evaluation
In addition to mechanisms to promote communication
up and down the hierarchy of staff team members, it is
valuable to consider the interaction between teams
conducting different components of the evaluation and
different sets of activities. Our evaluations consisted of
multiple teams conducting different evaluation activities
for quantitative, clinical, process, or qualitative outcomes.
Projects typically intend to bring together results from dif-
ferent components at the end of the project. However, our
experiences point to the value of dialogue during the trial,
with benefits not only for interpreting the trial results, but
also for informing decision-making to improve implemen-
tation of intervention and evaluation activities.
In one study in Uganda (study 1), a qualitative research
team conducted process evaluation activities alongside
ongoing intervention activities, with reflections and
emerging findings being shared with the broader study
team and principal investigators at regular meetings.
An example of the value of this communication came
from the ongoing analysis of in-depth interviews with
health workers, who had received training as part of
the intervention and who were asked to record a small
amount of information in the health facility register in
addition to routine data collected. The sharing of
emerging findings from these interviews highlighted
dissatisfaction among some health workers relating to
the perceived extra burden of work created by involve-
ment in the trial, and the reluctance of some to record
data as requested without additional payments or ben-
efits. The structures in place enabled the qualitative re-
search team to communicate these issues in a timely
way, resulting in discussion among the broader study
team about how to address health workers’ concerns
and the potential impact of any changes made on the
interpretation of the intervention’s effect. It was de-
cided to supply pens, sugar, and tea to all health facil-
ities enrolled in the trial to recognise health workers’involvement and support the ongoing work required to
collect the additional health facility data. This decision
was carefully noted for assessing the exact nature of the
intervention as received and experienced by health workers,
and for future interpretation of the trial results.
Literature exploring the different components of eval-
uations of complex interventions has tended to focus on
the incorporation of these at the point of the final ana-
lysis of a trial, for example in terms of the value of
process evaluation data for interpreting effects seen [13]
or of the methodological and epistemological challenges
of synthesizing multiple sources of data [10]. However,
this approach overlooks the potential value of ongoing
dialogue between the different strands of a study team
and their activities as the evaluation is being conducted.
Others have identified the benefits of building qualitative
work early into the implementation of a trial to highlight
challenges faced ‘in the field’ with conducting interven-
tion and evaluation activities and to help their timely
resolution [39,40]. Building on this, we recommend en-
abling effective team collaboration wherein experiences
and observations from work done by different study
components and team members from all levels feel en-
gaged and encouraged to contribute their interpretation
of research activities as the trial progresses. Combining
interpretations from various disciplinary perspectives
may help study teams to develop creative and appropri-
ate responses to challenges faced, and promote ongoing
reflection of their scientific implications. In addition, co-
ordination between different groups during trial imple-
mentation may help to overcome any challenges faced
at the point of analysis, in synthesizing multiple data
sources from different disciplinary perspectives [41].
The role of field research coordinator
Our collective experiences also pointed to the value of
having in the project team one (or more) person(s) who
takes responsibility for managing the day-to-day duties
of evaluation activities as planned, but who also has the
capacity (and time) to reflect on the activities in the field
from a broader scientific perspective. This vital role
should bridge the functions of overseeing coordination
of activities and problem solving, understanding what is
happening ‘on the ground’ in the context of the evalu-
ation, and the ongoing reflection and interpretation of
the potential impact on the study’s results. The position
of the field research coordinator (or other, similar title
such as ‘field manager’) would thus be able to align day-
to-day project management with an in-depth under-
standing of the scientific implications of decisions made
and be in a position to discuss this with the principal
investigators, and contribute to the scientific oversight
of the study including development of study protocols,
evaluation activities, and analysis plans. This may be
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vestigators and/or scientific leads are situated away
from the field site(s) for the study.
Across the studies represented here the role of field
research coordinator was increasingly recognised as im-
portant as the projects entered and progressed through
their life cycles. In our Ugandan projects (1, 2 and 3), a
field research coordinator was located in or near to the
main field sites in order to become aware of and address
unexpected challenges or events arising in the enactment
of evaluation activities on a day-to-day basis. It was con-
sidered important that this person had a thorough under-
standing and involvement in the scientific oversight of the
project. This helped them relate every day issues en-
countered to the research objectives, recognising where
changes or additions might be required in order to ensure
data collected were meaningful, and helped the communi-
cation of difficulties or complications, and their potential
solutions, to senior investigators. This was often a challen-
ging role to play in terms of the levels of responsibility
faced in both project and research management, but
field research coordinators agreed that they were very
well placed to understand in detail how activities played
out in the field and to feed this into their contributions
to the analysis of evaluation data and interpretations of
results. In the Cameroon trial (study 5a), an investigator
noted the absence of such a position in the qualitative
study team as challenging in relation to maintaining
staff members’ interest and understanding of the social
science activities in the field. The field staff had had lim-
ited experience in social science due to local capacity
constraints, and until the lack of field research coordinator
for these activities was addressed, the team struggled to
balance the demands of day-to-day project management
with a broader level of thinking in relation to the overall
research question. The investigators acknowledged this
may have limited the scope, flexibility, and responsiveness
of the social science activities in relation to ongoing reflec-
tions of the intervention as it was implemented, as the
team were less likely and/or willing to explore beyond the
original research questions and topic guide.
The need to build capacity in low-income settings for
skilled research coordinators who can manage clinical
trials with a scientific perspective in local settings has
been previously identified [42]. In addition, the import-
ance of the ‘hidden work’ required of a trial manager to
establish and maintain trial processes within a clinical
context has also been acknowledged [43]. We recom-
mend that this position is recognised as playing a vital
role in bridging the evaluation activity ‘in the field’
with the higher level interpretation of data and results,
thus negotiating the practical and the scientific work of
an evaluation in order to generate meaningful results.
To achieve this, the field research coordinator shouldideally be situated close to the study field sites, have an
in-depth and ongoing understanding of the intervention
and evaluation objectives and be provided with appropriate
resources and support to both manage day-to-day research
activities and reflect on them in light of the overall project.
Keeping field notes
In addition to the established guidance and requirements
for management of data in trials, for example the Good
Clinical Practice guidelines [23], our experiences led us to
consider the value of ongoing reflection and documentation
of the evaluation in action. This is to capture contextual
influences and changes that arise, decisions made in re-
sponse, and reflections on these, to inform data analysis
in the future. Process evaluation methods are valuable
for documenting the contextual influences on the roll out
of an intervention [14]; however, they do not routinely cap-
ture information on how those influences impacted on the
rollout of evaluation activities, and thus the data collected.
As discussed above, this reflection can occur through regu-
lar communications within and between research teams,
ideally led by the field research coordinator or other project
leads situated close to the field activities.
In the case of some of our studies, the time period of
evaluation activities lasted for up to two years before
formal analysis was conducted which hints at the po-
tential challenges for trying to recall information about
contextual influences at the point of interpretation of
the data. For two studies in Uganda (2 and 3), the study
coordinator actively recorded information in extensive
field diaries throughout the period of conducting evalu-
ation activities. He described making records following
every trip to the field sites, interactions with the field
teams, and noting difficulties or questions arising with
data collection. An example issue recorded was dissatis-
faction expressed by community medicine distributors
(CMDs) in study 2 when their patients were followed up
by study interviewers. Subsequent changes were made,
for example conducting additional sensitization by the
local study team to alleviate CMDs’ fears around their
practice being ‘monitored.’ The coordinator anticipated
the field diary would be particularly useful at the ana-
lysis stage for exploring reasons behind missing data
from the evaluation data collection activities in study 3,
for interpreting any patterns of reporting by drug shop
vendors, to understand how the trial was being con-
ducted and perceived by participants at that time. As
such, he felt the field notes taken would be a valuable
resource for reminding him of his ongoing reflections
during the enactment of the evaluations, and feeding
into interpretation of the results.
The ‘paramount importance’ of an audit trail for data
management within a trial [44] has been emphasised
through trial regulations and guidance [23]. However,
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on changes to SOPs, data collection forms, and/or data-
bases e.g., [45]. We recommend the use of field notes to
promote a continuous, inward reflection on the activity
of an evaluation, to facilitate meaningful interpretation
of the trial results. In addition, regular reviewing of field
notes during the period of evaluation may help identify
problems or questions that can be addressed in real
time as they arise. This approach extends the focus of a
process evaluation to documenting the reality of con-
ducting the evaluation (in addition to the intervention),
and echoes the reflexive perspective adopted within an-
thropological methods in the use of ethnographic field
notes e.g., [46]. The continuous recording and contem-
plation of the data collection process facilitates identifi-
cation of the influences on the data collection process,
including the subjective role played by the researcher
(and research team) [47]. Hence, we recommend that
mechanisms be built into the process of conducting
evaluations to encourage study team members to capture
their day-to-day experiences of evaluation activities, and
to facilitate the regular reviewing of these notes and the
systematic linking of them to the evaluation activities at
the data interpretation stage.
Addressing overlap between intervention and evaluation
The final lesson learned from our experiences relates to
the identification and management of overlaps between
evaluation and intervention activities in the field, and
the consideration of potential consequences of this for
interpreting the results of the trial. Careful planning and
piloting of protocols and procedures should help to limit
the possibility of evaluation activities interacting with the
intervention, for example through separating the timing of
conducting intervention and evaluation activities. However,
from the perspective of the participants, both interven-
tion and evaluation activities may be experienced and
interpreted as the ‘intervention’. The ‘Hawthorne effect’,
postulates that behaviour may be changed through
awareness of being watched or evaluated. Studies can take
this into account in design as something to be minimized
and/or accounted for in analysis [48]. In addition, asking
questions of participants, for example in process evaluation
activities, may be interpreted as an intervention, with im-
pacts on how individuals think, perceive the programme,
and ‘perform’ trial outcomes [40]. Studies may, to some
extent, be able to control for these effects by ensuring
consistent activities in both intervention and control
arms in a controlled trial design. Our experience sug-
gests, however, the need to consider also a possible ef-
fect of evaluation activities changing or modifying the
nature of the intervention itself, the perception of what
constitutes the intervention by the recipients, and the
intended mechanisms of change through which outcomesare realized. There are no easily identifiable guidelines on
methods to identify and accommodate such interactions as
they occur during a trial in action.
In one study in Tanzania (9), field staff conducting the
evaluation of various components of an intervention to
support health workers’ uptake of and adherence to RDTs
for malaria were required to attend participating health fa-
cilities every six weeks to collect health worker-completed
data forms and to monitor RDT stock levels. An investiga-
tor from this study described how they restricted these
visits to a few specific tasks to minimize the impact on the
health workers and their practice, and tried to conduct
these activities similarly in both the intervention and con-
trol arms. Although from the perspective of the investiga-
tors and the study, these visits were ‘evaluation activities’,
health workers could have interpreted interactions with
field staff as ‘supervision’. This carried potential for a more
pronounced Hawthorne effect for those in the inter-
vention arms as they may have been more attuned to
the behaviour seen as ‘appropriate’ by evaluators. These
concerns about the possible interaction between evalu-
ation activities and the intervention were echoed by inves-
tigators in another study in Uganda (1), where concern
was expressed that visits to health facilities by field staff to
collect surveillance data could be perceived as supervision,
with potential for impact on practice in a context where
supervision was infrequent. Investigators reflected on the
difficulties of identifying, and deciding to what extent, and
how to accommodate the possible effects of these activities
on the nature of the intervention they were evaluating.
A challenge for these projects was to know exactly what
the ‘intervention’ was from the perspective of recipients.
This has implications for generalisability, to inform future
scale-up or implementation of the intervention in other set-
tings. While steps can be taken to anticipate and minimize
overlaps between evaluation and intervention activities, our
experience suggests that it is (almost) impossible to plan for
all interactions that may occur when a trial is being con-
ducted in the field. We recommend building into a trial a
set of mechanisms to facilitate the identification and reflec-
tion on overlaps as they arise, and suggest that the actions
and processes described in the lessons learned above would
be instrumental for achieving this.
Conclusion
In order to inform appropriate and effective implementa-
tion and scale-up of health and health service interventions,
evaluations need to be useful and reflect the reality of the
trial context. Just as interventions may not be implemented
as planned, the ‘doing’, or enactment of evaluation activities
may not be aligned in real-life with intentions and as-
sumptions made in the planning stage. Changes arise,
challenges are faced, and decisions are made, which all
form part of the process of producing data for analysis
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of complex behavioural interventions are typically subject-
ively measured and therefore their evaluation needs to be
understood as an interpretive process, subject to the vary-
ing influences of the actors, activities and contexts that
are engaged in an evaluation.
Our experiences of conducting evaluations of complex
interventions in low-income country settings included
negotiating a variety of day-to-day challenges that arose
in the ‘doing’ of evaluation during the trial in action, and
which reflected the specific networks of people, objects,
relationships, and concepts in which trials operated. These
issues could not easily have been predicted during the
planning or piloting phases of our studies, and required a
number of supporting structures (e.g., mechanisms for
communicating, documenting and reflecting on the reality
of the evaluation) in order to ensure data collected would
be meaningful for the interpretation of the trial outcomes
and informing decisions on scale-up of an intervention.
As a result of reflection on these experiences, we propose
a set of ‘lessons learned’ that could be implemented
systematically to improve future evaluation practice; a
summary of these is presented in Table 2. At the core
of our recommendations is the promotion of an ongoing,
reflexive consideration of how the reality of enacting evalu-
ation activities can impact the meaningful interpretation
of trial results, thus enhancing the understanding of the
research problem [50].
Reflexivity has been recognised as an ongoing, critical
‘conversation’ about experiences as they occur, and
which calls into question what is known during the re-
search process, and how it has come to be known [51].
The aim of reflexivity, then, is to reveal the sets of personal
perspectives, interactions, and broader socio-political con-
texts that shape the research process and the construction
of meaning [52]. Initial calls have been made for investiga-
tors to adopt a reflexive approach to reporting challenges of
and changes to trials due to contextual factors affecting
intervention delivery that may impact on the interpretation
of internal and external validity [11,53,54]. Wells et al. rec-
ommend adaptation of the CONSORT reporting guidelines
to support reflexive acknowledgment of how investigators’
motivations, personal experiences, and knowledge influ-
ence their approach to the delivery of an intervention in
a research context, to better inform clinical and policy
decision-making [11]. We argue for an extension of this
perspective, centred on the intervention delivery, to reflex-
ive consideration of the process of conducting evaluation
activities in a trial. The ‘complexity and idiosyncratic na-
ture’ of a trial [11], p14 does not affect only the delivery of
the intervention, but the delivery of the evaluation activ-
ities also, and thus a reflexive approach would encourage
greater awareness of the processes involved in enacting
the protocol for an evaluation in a real-life context, andsupport more detailed reporting of these processes to aid
decision-making. A reflexive approach could also facilitate
a systematic consideration of the entirety of the evaluation
and its activities, not just discrete stages of the trial such
as recruitment or specific aspects such as ethics, quality
assurance, or project management, as has been seen
previously. Acknowledgment that conducting an evalu-
ation is never as straightforward as a (comparatively)
simplistic protocol would suggest on paper, and helping
research staff members to reflect on their own role in
the negotiations and nuances of the trial in action can
lead to more informed and useful interpretations of the
evaluation outcomes.
The events and questions that arose during our evalu-
ations are unlikely to be unique to the trials of complex
interventions alone, but familiar to those conducting
other types of health intervention research. Additionally,
we acknowledge that our experiences may not be repre-
sentative of all other trials of complex interventions, ei-
ther in low-income settings or beyond. We propose that
the general principles behind our lessons learned could
be valuable for other investigators evaluating interven-
tions and/or conducting operational research, and balan-
cing the demands for both internal and external validity
of their trial. Rather than being seen as an ‘additional ac-
tivity’, we recommend that this reflexive perspective be
embedded within what is considered ‘good practice’ for
the everyday conduct of a trial evaluating a complex
intervention. We acknowledge that it will require efforts
to create time and space to think about the progress of a
trial, and that within a typical trial culture of working
against the clock, this could prove challenging for some
research teams. However, we suggest that taking this
time will make for better practice in the long term, and
that with increased practice, a reflexive perspective will
become easier and more established in the trials of
public health interventions. Extending the perspective
offered in process evaluation approaches to consider
the role of conducting evaluation activities themselves
in the production of trial results, will surely increase
understanding of what works and under what condi-
tions [1,55], thus better informing effective scale-up
and implementation of interventions.
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Additional file 1: A summary of the first order constructs
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identification of ‘lessons learned’.
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